Active Ingredient History

  • Now
Bretylium (bretylium tosylate) is an antifibrillatory and antiarrhythmic agent. Bretylium is abromobenzyl quaternary ammonium compound which selectively accumulates in sympathetic ganglia and their postganglionic adrenergic neurons where it inhibits norepinephrine release by depressing adrenergic nerve terminal excitability. The drug has a direct positive inotropic effect on the myocardium and blocking effect on postganglionic sympathetic nerve transmission. The drug is poorly absorbed orally, requiring either i.m. or i.v. administration.   NCATS

  • SMILES: CC[N+](C)(C)Cc1ccccc1Br
  • Mol. Mass: 243.17
  • ALogP: 3.05
  • ChEMBL Molecules:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No
(2-bromobenzyl)ethyldimethylaminium | 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium | asl-603 | brethyllium | bretylan | bretylate | bretylium | bretylium bromide | bretylium chloride | bretylium iodide | bretylium tosilate | bretylium tosylate | bretylol | n-ethyl-n,n-dimethyl-2-bromobenzenemethanaminium


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue